Join
Live feed
·
PRReleasevia Quantisnow
Tactile Systems Technology Inc. logo

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

ByQuantisnow·Wall Street's wire, on your screen.
TCMD· Tactile Systems Technology Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TCMD (Tactile Systems Technology Inc.) and more on Quantisnow.